Notice of first launch, interruption or termination of supply of a human drug
 Date ▲HolderCodeDrugDate fromSubject
 14.12.2021Pfizer Europe MA EEIG (PFI-BE-3)8199CVFEND 200 mg filmom obalené tablety (tbl flm 14x200 mg (blis.PVC/Al/PVC/PVDC))31.12.2021R
 14.12.2021Pfizer Europe MA EEIG (PFI-BE-3)40536DEPO-MEDROL 40 mg/ml (sus inj 1x5 ml/200 mg (liek.inj.skl.))17.12.2021R
 14.12.2021B.Braun Melsungen AG (BME)93580CALCIUM GLUCONICUM 10 % B. Braun (sol inj 20x10 ml (amp.LDPE))14.12.2021R
 14.12.2021Takeda GmbH (TKD-3)90763EBRANTIL i.v. 25 (sol ijf 5x5 ml/25 mg (amp.skl.))16.12.2021R
 14.12.2021Pierre Fabre Dermatologie (PAH)49915CURACNÉ 40 mg (cps mol 30x40 mg)15.12.2021Z
 14.12.2021Opella Healthcare Slovakia s.r.o. (OPL)56735Essentiale 300 mg (cps dur 50x300 mg (blis.Al/PVC))11.10.2021Z
 14.12.2021XANTIS PHARMA LIMITED (XNT-1)6300CMOXTENZ 0,2 mg (tbl flm 100x0,2 mg (blis.PVC/PVDC/Al))15.12.2021Z
 14.12.2021XANTIS PHARMA LIMITED (XNT-1)8266BZolpidem Xantis 10 mg (tbl flm 20x10 mg (blis.PVC/PVDC/Al))15.12.2021R
 14.12.2021Adamed Czech Republic s.r.o. (AAZ)00142Licobondrat 150 mg (tbl flm 3x150 mg (blis.Al/Al))31.12.2021Z
 14.12.2021MEDOCHEMIE Ltd. (MOE)0910AVAPRESS 80 mg (tbl flm 28x80 mg (blis.PVC/PE/PVDC/Al))20.12.2021O
 14.12.2021MEDOCHEMIE Ltd. (MOE)34921MEDOFLOXINE 200 mg (tbl flm 10x200 mg (blis.PVC/Al))1.1.2022R
 14.12.2021MEDOCHEMIE Ltd. (MOE)34922MEDOFLOXINE 200 mg (tbl flm 20x200 mg (blis.PVC/Al))1.1.2022R
 14.12.2021MEDOCHEMIE Ltd. (MOE)38709Elify XR 75 mg tvrdé kapsuly s predĺženým uvoľňovaním (cps pld 28x75 mg (blis.PVC/Al))20.12.2021O
 14.12.2021MEDOCHEMIE Ltd. (MOE)4031CDinarex 1,5 mg/ml sirup (sir 1x200 ml (fľ.skl.hnedá s Al viečkom+odmer.lyž.))1.1.2022R
 14.12.2021MEDOCHEMIE Ltd. (MOE)64831AXETINE 1,5 g (plo jof 10x1,5 g (liek.inj.skl.))1.1.2022R

Subject means:
U-Placement of medicine to Slovakian market, R-Discontinuation of medicine supply to Slovakian market,
O-Resumption of medicine supply to Slovakian market, Z-Cancelation of medicine supply to Slovakian market


Date from
From
To



 
Processed by the system MCR.Prerusenie (8.0)